KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group.
Amy K ErbeMitch B DiccianniRajen ModyArlene NaranjoFan F ZhangJen BirstlerKyungMann KimArika S FeilsJung-Tung HungWendy B LondonBarry L ShulkinVarsha MathewMarguerite T ParisiSabah ServaesShahab AsgharzadehJohn M MarisJulie ParkAlice Lin-Tsing YuPaul M SondelRochelle BagatellPublished in: Journal for immunotherapy of cancer (2023)
NCT01767194.